Targeting RNA Processing Defects of Ewing Sarcoma
Targeting RNA Processing Defects of Ewing Sarcoma
UT Health Science Center at San Antonio, San Antonio, TX
Developing A Novel Therapeutic Strategy for Rhabdomyosarcoma
Developing A Novel Therapeutic Strategy for Rhabdomyosarcoma
UT Southwestern Medical Center, Dallas, TX
Targeting Signaling Pathways that Confer Cytarabine Resistance in Pediatric AML
Targeting Signaling Pathways that Confer Cytarabine Resistance in Pediatric AML
Baylor College of Medicine, Houston, TX
Predicting Post-Treatment Relapse in Pediatric AML Using Single-Cell Proteomics
Predicting Post-Treatment Relapse in Pediatric AML Using Single-Cell Proteomics
Stanford University, Stanford, CA
Molecular Mechanism of CAR Activation in Targeting B Cell Leukemia
Molecular Mechanism of CAR Activation in Targeting B Cell Leukemia
Yale University, New Haven, CT
Disrupting Neuroblastoma Tumor-Initiating Cells
Disrupting Neuroblastoma Tumor-Initiating Cells
University of Rochester, Rochester, NY
Epigenetic Drivers in Rhabdomyosarcoma
Epigenetic Drivers in Rhabdomyosarcoma
University of Washington, Seattle, WA
Targeting MEK and CDK4/6 in DIPG
Targeting MEK and CDK4/6 in DIPG
Lurie Children’s Hospital, Chicago, IL
Targeting Beta-Catenin Mediated Activity in Metastatic Osteosarcoma
Targeting Beta-Catenin Mediated Activity in Metastatic Osteosarcoma
Baylor College of Medicine, Houston, TX
Improving Brain Tumor Targeted Antigen Receptor T Cell Function
Improving Brain Tumor Targeted Antigen Receptor T Cell Function
City of Hope, Duarte, CA
Preclinical Development of Novel Immunotherapies for Pediatric Acute Myeloid Leukemia (AML)
Preclinical Development of Novel Immunotherapies for Pediatric Acute Myeloid Leukemia (AML)
Children’s Hospital of Philadelphia, Philadelphia, PA
In-Vivo Organogenesis Approach to Elucidate Drivers of Medulloblastoma Development and Identify Therapeutic Targets
In-Vivo Organogenesis Approach to Elucidate Drivers of Medulloblastoma Development and Identify Therapeutic Targets
University of California, San Francisco, CA
Pediatric ALL CAR T-Cell Therapy
Pediatric ALL CAR T-Cell Therapy
Seattle Children’s Hospital, Seattle, WA
Phase I Polio Oncolytic Virotherapy (PVS-RIPO) of Pediatric High-Grade Glioma
Phase I Polio Oncolytic Virotherapy (PVS-RIPO) of Pediatric High-Grade Glioma
Duke University Medical Center, Durham, NC
Tumorigenesis of a Pediatric Liver Cancer
Tumorigenesis of a Pediatric Liver Cancer
The Rockefeller University, New York, NY
Defining Actionable Apoptotic Dependencies in Pediatric CNS Tumors
Defining Actionable Apoptotic Dependencies in Pediatric CNS Tumors
John B. Little Center for Radiation Sciences, Harvard Chan School, Boston, MA
MicroNRA Regulation of Cancer Stem Cells in Nervous System Tumors
MicroNRA Regulation of Cancer Stem Cells in Nervous System Tumors
Baylor College of Medicine, Houston, TX
‘Eyes Absent’ Gene Investigation in Ewing’s Sarcoma Patients
‘Eyes Absent’ Gene Investigation in Ewing’s Sarcoma Patients
Cincinnati Children’s Hospital, Cincinnati, OH
Pediatric Cancer Genome Project
Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital, Memphis, TN